Close Menu

It's Not That Simple

Thanks to a new test, checking for genetic abnormalities in a fetus is easier and less invasive — but there's a downside, says Nature News' Erika Check Hayden. Sequenom's new MaterniT21 Down syndrome test requires only a small sample of the mother's blood, and is only one of several similar tests expected to hit the market soon, Hayden says. While such tests spare women from amniocentesis or other invasive procedures, doctors say they pose other problems, Hayden says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.